InvestorsHub Logo
Followers 46
Posts 6362
Boards Moderated 0
Alias Born 06/17/2009

Re: baltimorebullet post# 184511

Sunday, 03/10/2019 9:09:25 PM

Sunday, March 10, 2019 9:09:25 PM

Post# of 469827
So, BB, let's state that a P3 is necessary. In the P2 trial, the placebo folks showed no progress whereas the 2-73-dosed people demonstrated improvement.

If a P3 were required by the EU neo's, for those taking the placebo, do those folks get the choice of continuing with the placebo or are they given a choice to switch to one of the 2-73 doses? What is morally right at that point?

Also, at whet point when evident that placebo participants have requested to take up 2-73, does it require disclosure?


Anavex Now ...Mono-style ... and Life!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News